DexCom
DXCM
1,032 hedge funds and large institutions have $51.1B invested in DexCom in 2024 Q1 according to their latest regulatory filings, with 155 funds opening new positions, 403 increasing their positions, 348 reducing their positions, and 86 closing their positions.
80% more first-time investments, than exits
New positions opened: 155 | Existing positions closed: 86
16% more repeat investments, than reductions
Existing positions increased: 403 | Existing positions reduced: 348
8% more capital invested
Capital invested by funds: $47.5B → $51.1B (+$3.58B)
6% more funds holding
Funds holding: 974 → 1,032 (+58)
0% more funds holding in top 10
Funds holding in top 10: 25 → 25 (0)
3.6% less ownership
Funds ownership: 99.24% → 95.65% (-3.6%)
11% less call options, than puts
Call options by funds: $686M | Put options by funds: $770M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$639M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$255M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$254M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$155M |
| 5 |
BlackRock
New York
|
+$150M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$650M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
-$523M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$321M |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$291M |
| 5 |
AI
Alphabet Inc
Mountain View,
California
|
-$238M |
DXCM Hedge Fund Activity: Q1 2024 in Review
1,032 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q1 2024, worth a combined $51.1B — up 7.5% from $47.5B a quarter earlier.
Buyers outnumbered sellers: 155 funds opened new DXCM positions and 86 closed out — a net gain of 69 holders — while 403 added to existing stakes and 348 trimmed.
The largest buyer was DZ Bank, adding an estimated $639M. The largest seller was Morgan Stanley, cutting an estimated $650M.
- 1,032 institutional investors held DexCom (DXCM) as of Q1 2024, up from 974 in Q4 2023.
- Funds reported $51.1B of DexCom stock for Q1 2024, up 7.5% quarter-over-quarter.
- 155 funds opened new DexCom positions in Q1 2024 and 86 closed out, a net change of +69 holders.
- The largest DexCom buyer in Q1 2024 was DZ Bank, an estimated $639M added.
- The largest DexCom seller in Q1 2024 was Morgan Stanley, an estimated $650M sold.
Based on aggregated 13F filings for Q1 2024.